Benchmark Holdings Regulatory News (BMK)

11 November 2019

Benchmark Holdings plc

("Benchmark" or the "Company")

Chief Financial Officer Appointment Update

Benchmark, the aquaculture health, nutrition and genetics business, is pleased to provide an update following the Company's 14 August 2019 announcement of the appointment of Septima Maguire as Chief Financial Officer.

Septima has joined the business today, but will be appointed CFO with effect from 18 December 2019. Mark Plampin remains CFO of the Group until that date to ensure an effective transition.

Septima joins Benchmark from Dechra Pharmaceuticals PLC, the FTSE 250 international provider of specialist veterinary pharmaceuticals and related products, where she spent four years. Having joined as Group Financial Controller she was Acting Group Finance Director between 2016 and 2017. She was most recently Corporate Development Director overseeing all aspects of acquisition activities, strategic projects, business development and investment initiatives playing a significant role in supporting the company during a period of high growth.

Previously, Septima held a number of senior finance roles at Ardagh Group S.A., the international packaging manufacturer with revenues of €9.1bn, over a period of six years.

Enquiries

Katie Hunt / Reg Hoare / Alistair de Kare-Silver benchmark@mphc.com

About Benchmark Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com